Researchers at Uppsala University have uncovered new pathways by which the Semliki Forest virus infiltrates the central nervous system.
Their findings reveal that the virus first infiltrates the cerebrospinal fluid before binding to specific cell types.
This research, published in the prestigious journal Nature Communications, marks a significant advance in virology, particularly in the fight against neurological diseases.
The Semliki Forest virus, originally isolated from mosquitoes in Uganda’s Semliki Forest, is known to cause mild blood viremia following systemic infection via mosquito bites.
Understanding its pathways into the brain has been a longstanding objective within the field of virology.
Recently, researchers identified Very Low-Density Lipoprotein Receptor (VLDLR) as the primary receptor enabling the Semliki Forest virus to enter host cells.
Their discoveries confirmed the importance of choroid plexus cells, which are responsible for producing cerebrospinal fluid, as the entry point for the virus.
The implications of this research extend well beyond the basic virology of the Semliki Forest virus.
Given that oncolytic viruses are being explored as a novel immunotherapy for cancer treatment, the capacity of the Semliki Forest virus to penetrate brain tissues opens exciting avenues for its potential application in treating aggressive brain cancers, particularly glioblastoma.
As researchers continue to unravel the complexities of how the Semliki Forest virus interacts with neural tissues, they aim to refine the delivery mechanisms of this viral agent for use in clinical trials.